Liu, J., Guo, J., Sheng, X., Wen, H., Zhou, C., Liu, L., Li, W., Quan, M. (2026). Phase I/II study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in combination with LB4330, a long-acting IL-10, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2626